Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.45 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | NR1H4 | Q96RI1 | 4/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | ANPEP | P15144 | 1/20 | 0.43 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11668645 | 0.86 | CA2 (0.52) | CA2CAMK2AAKR1B1ALDH1A1HPGD | |
| SCHEMBL2970528 | 0.83 | CA2 (0.48) | CA2CAMK2AAKR1B1ALDH1A1HPGD | |
| SCHEMBL9518384 | 0.81 | PTGS1 (0.50) | ALDH1A1HPGDLMNATSHRPTGS1 | |
| SCHEMBL10716596 | 0.77 | ATM (0.55) | ALDH1A1LMNAGAATSHR | |
| SCHEMBL2329814 | 0.77 | ATM (0.55) | ALDH1A1LMNAGAATSHR | |
| SCHEMBL13232550 | 0.77 | HDAC1 (0.35) | ALDH1A1HPGDHSD17B10LMNATSHR | |
| SCHEMBL10838346 | 0.77 | ALDH1A1 (0.56) | ALDH1A1HPGDHSD17B10 | |
| SCHEMBL10978746 | 0.76 | CA2 (0.54) | CA2CAMK2AAKR1B1ALDH1A1HPGD | |
| SCHEMBL28872737 | 0.76 | ANPEP (0.55) | CA2CAMK2AAKR1B1ALDH1A1HPGD | |
| SCHEMBL69614 | 0.76 | CA2 (0.79) | CA2CAMK2AAKR1B1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3415171-B1 | SYSTEM AND METHOD FOR HEALING A WOUND AT A TISSUE SITE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-12-14 | — | — | EP | claimed |
| EP-3415171-A1 | SYSTEM AND METHOD FOR HEALING A WOUND AT A TISSUE SITE | KCI Licensing, Inc. (US) | 2018-12-19 | — | — | EP | claimed |
| EP-2244748-A2 | SYSTEM AND METHOD FOR HEALING A WOUND AT A TISSUE SITE | KCI Licensing, Inc. (US) | 2010-11-03 | — | — | EP | claimed |
| WO-2009108884-A2 | SYSTEM AND METHOD FOR HEALING A WOUND AT A TISSUE SITE | KCI LICENSING INC. (US) | 2009-09-03 | — | — | WO | claimed |
| US-20090216170-A1 | SYSTEM AND METHOD FOR HEALING A WOUND AT A TISSUE SITE | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2009-08-27 | — | — | US | claimed |
| US-5482719-A | Drug delivery systems | MEDIPRO SCIENCES LIMITED (CA) | 1996-01-09 | — | — | US | claimed |
| WO-1994009826-A2 | DRUG DELIVERY SYSTEMS, CHARACTERISED BY A PHOTOLABILE LINKAGE | MEDIPRO SCIENCES LIMITED (CA) | 1994-05-11 | — | — | WO | claimed |
| EP-4572795-A2 | METHODS AND COMPOSITIONS FOR TREATING CANCER WITH CANCER-BINDING ADJUVANTS | The University of Chicago (US) | 2025-06-25 | — | — | EP | disclosed |
| US-20250122502-A1 | Bifunctional Molecules and Methods of Using Thereof | FLAGSHIP PIONEERING, INC. (US) | 2025-04-17 | — | — | US | disclosed |
| US-20250114441-A1 | POLYMERIC VACCINE FOR OPIOID ADDICTION | THE JOHNS HOPKINS UNVERSITY | 2025-04-10 | — | — | US | disclosed |
| US-20240400684-A1 | ANTIBODY-MEDIATED DELIVERY OF CAS9 TO MAMMALIAN CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-12-05 | — | — | US | disclosed |
| WO-2024040169-A2 | METHODS AND COMPOSITIONS FOR TREATING CANCER WITH CANCER-BINDING ADJUVANTS | THE UNIVERSITY OF CHICAGO (US) | 2024-02-22 | — | — | WO | disclosed |
| US-20230332145-A1 | BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF | FLAGSHIP PIONEERING, INC. (US) | 2023-10-19 | — | — | US | disclosed |
| EP-2244748-A2 | SYSTEM AND METHOD FOR HEALING A WOUND AT A TISSUE SITE | KCI Licensing, Inc. (US) | 2010-11-03 | — | — | EP | disclosed |
| WO-2009108884-A2 | SYSTEM AND METHOD FOR HEALING A WOUND AT A TISSUE SITE | KCI LICENSING INC. (US) | 2009-09-03 | — | — | WO | disclosed |
| US-20090216170-A1 | SYSTEM AND METHOD FOR HEALING A WOUND AT A TISSUE SITE | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2009-08-27 | — | — | US | disclosed |
| US-5726243-A | Mild solid-phase synthesis of aligned, branched triple-helical peptides | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1998-03-10 | — | — | US | disclosed |
| US-5576419-A | Mild solid-phase synthesis of aligned branched triple-helical peptides | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1996-11-19 | — | — | US | disclosed |
| US-5482719-A | Drug delivery systems | MEDIPRO SCIENCES LIMITED (CA) | 1996-01-09 | — | — | US | disclosed |
| WO-1994009826-A2 | DRUG DELIVERY SYSTEMS, CHARACTERISED BY A PHOTOLABILE LINKAGE | MEDIPRO SCIENCES LIMITED (CA) | 1994-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250114441-A1 | POLYMERIC VACCINE FOR OPIOID ADDICTION | OPRM1, OPRK1, OPRL1 | CA2 4595/4885CAMK2A 1048/4885AKR1B1 2741/4885 |
| US-20230332145-A1 | BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF | EFTUD2, DDX21, SNRPE | CA2 4173/4885CAMK2A 3105/4885AKR1B1 4068/4885 |
| US-20250122502-A1 | Bifunctional Molecules and Methods of Using Thereof | EFTUD2, DDX21, SNRPE | CA2 4173/4885CAMK2A 3105/4885AKR1B1 4068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.